alpha-Catenin interacts with APC to regulate beta-catenin proteolysis and transcriptional repression of Wnt target genes

Academic Article
uri icon

publication date

  • 2013

abstract

  • Mutation of the adenomatous polyposis coli (APC) tumor suppressor stabilizes ?-catenin and aberrantly reactivates Wnt/?-catenin target genes in colon cancer. APC mutants in cancer frequently lack the conserved catenin inhibitory domain (CID), which is essential for ?-catenin proteolysis. Here we show that the APC CID interacts with ?-catenin, a Hippo signaling regulator and heterodimeric partner of ?-catenin at cell:cell adherens junctions. Importantly, ?-catenin promotes ?-catenin ubiquitylation and proteolysis by stabilizing its association with APC and protecting the phosphodegron. Moreover, ?-catenin ubiquitylation requires binding to ?-catenin. Multidimensional protein identification technology (MudPIT) proteomics of multiple Wnt regulatory complexes reveals that ?-catenin binds with ?-catenin to LEF-1/TCF DNA-binding proteins in Wnt3a signaling cells and recruits APC in a complex with the CtBP:CoREST:LSD1 histone H3K4 demethylase to regulate transcription and ?-catenin occupancy at Wnt target genes. Interestingly, tyrosine phosphorylation of ?-catenin at Y177 disrupts binding to APC but not ?-catenin and prevents repression of Wnt target genes in transformed cells. Chromatin immunoprecipitation studies further show that ?-catenin and APC are recruited with ?-catenin to Wnt response elements in human embryonic stem cells (hESCs). Knockdown of ?-catenin in hESCs prevents the switch-off of Wnt/?-catenin transcription and promotes endodermal differentiation. Our findings indicate a role for ?-catenin in the APC destruction complex and at Wnt target genes.
  • Mutation of the adenomatous polyposis coli (APC) tumor suppressor stabilizes β-catenin and aberrantly reactivates Wnt/β-catenin target genes in colon cancer. APC mutants in cancer frequently lack the conserved catenin inhibitory domain (CID), which is essential for β-catenin proteolysis. Here we show that the APC CID interacts with α-catenin, a Hippo signaling regulator and heterodimeric partner of β-catenin at cell:cell adherens junctions. Importantly, α-catenin promotes β-catenin ubiquitylation and proteolysis by stabilizing its association with APC and protecting the phosphodegron. Moreover, β-catenin ubiquitylation requires binding to α-catenin. Multidimensional protein identification technology (MudPIT) proteomics of multiple Wnt regulatory complexes reveals that α-catenin binds with β-catenin to LEF-1/TCF DNA-binding proteins in Wnt3a signaling cells and recruits APC in a complex with the CtBP:CoREST:LSD1 histone H3K4 demethylase to regulate transcription and β-catenin occupancy at Wnt target genes. Interestingly, tyrosine phosphorylation of α-catenin at Y177 disrupts binding to APC but not β-catenin and prevents repression of Wnt target genes in transformed cells. Chromatin immunoprecipitation studies further show that α-catenin and APC are recruited with β-catenin to Wnt response elements in human embryonic stem cells (hESCs). Knockdown of α-catenin in hESCs prevents the switch-off of Wnt/β-catenin transcription and promotes endodermal differentiation. Our findings indicate a role for α-catenin in the APC destruction complex and at Wnt target genes.